AOD-9604 in Campocavallo — Fat Loss Peptide Research Guide
AOD-9604 research guide for Campocavallo. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
Unlike general health products stocked in every health store, AOD-9604 is distributed via a specialist research supply market that Campocavallo residents reach through online vendors. This matters because AOD-9604 quality varies dramatically across the market — from pharmaceutical-grade 99%+ purity to mislabeled or underdosed compounds — and the vendor determines everything about the product. The key verification criteria for AOD-9604 are HPLC purity ≥98%, molecular identity established via mass spectrometry, and a bacterial endotoxin panel — all documented in a lot-traced Certificate of Analysis. This guide walks Campocavallo researchers through that evaluation process and explains how to verify AOD-9604 vendor quality step by step.
AOD-9604: What the Research Shows
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Campocavallo researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
How to Source AOD-9604 — Vendor Guide
Evaluating AOD-9604 vendors requires starting from the COA: access the batch-specific certificate prior to buying, not after. Mass spectrometry in the COA confirms that the main HPLC peak is actually AOD-9604 and not another compound with similar chromatographic behaviour — HPLC purity alone cannot verify molecular identity. For Campocavallo researchers evaluating new suppliers: a modest first purchase to test the product before scaling up your order is standard practice in the community. Bacteriostatic water is the correct reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order AOD-9604 — ships to Campocavallo
COA-verified · International tracking · Research grade
AOD-9604 operates outside the framework of pharmaceutical oversight — researchers should understand that the risk characterisation for this compound is based on preclinical evidence rather than regulated clinical data. Storage requirements for AOD-9604: lyophilised powder at freezer temperature, reconstituted solution stored refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with bac water. Endotoxin testing in the AOD-9604 COA is not optional — gram-negative bacterial endotoxins can trigger dangerous immune responses at trace quantities, and no pricing advantage justifies skipping this verification. The research literature on AOD-9604 should be studied thoroughly before planning any study — study designs, dosing ranges, and outcome measures vary significantly and not all findings translate directly.
Frequently Asked Questions
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
